Literature DB >> 19342624

Cutting edge: A critical role of B and T lymphocyte attenuator in peripheral T cell tolerance induction.

Xikui Liu1, Maria Alexiou, Natalia Martin-Orozco, Yeonseok Chung, Roza I Nurieva, Li Ma, Qiang Tian, George Kollias, Sijie Lu, Daniel Graf, Chen Dong.   

Abstract

T cell activation and tolerance are delicately regulated by costimulatory molecules. Although B and T lymphocyte attenuator (BTLA) has been shown as a negative regulator for T cell activation, its role in peripheral T cell tolerance induction in vivo has not been addressed. In this study, we generated a novel strain of BTLA-deficient mice and used three different models to characterize the function of BTLA in controlling T cell tolerance. In an oral tolerance model, BTLA-deficient mice were found resistant to the induction of T cell tolerance to an oral Ag. Moreover, compared with wild-type OT-II cells, BTLA(-/-) OT-II cells were less susceptible to tolerance induction by a high-dose OVA peptide administered i.v. Finally, BTLA(-/-) OT-I cells caused autoimmune diabetes in RIP-mOVA recipient mice. Our results thus demonstrate an important role for BTLA in the induction of peripheral tolerance of both CD4(+) and CD8(+) T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342624      PMCID: PMC2767106          DOI: 10.4049/jimmunol.0803161

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity.

Authors:  Y Morel; A Truneh; R W Sweet; D Olive; R T Costello
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

Review 2.  Costimulatory regulation of T cell function.

Authors:  C A Chambers; J P Allison
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

3.  Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.

Authors:  Myung-Shin Jeon; Alex Atfield; K Venuprasad; Connie Krawczyk; Renu Sarao; Chris Elly; Chun Yang; Sudha Arya; Kurt Bachmaier; Leon Su; Dennis Bouchard; Russel Jones; Mathew Gronski; Pamela Ohashi; Teiji Wada; Debra Bloom; C Garrison Fathman; Yun-Cai Liu; Josef M Penninger
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

4.  A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.

Authors:  Lino C Gonzalez; Kelly M Loyet; Jill Calemine-Fenaux; Vandana Chauhan; Bernd Wranik; Wenjun Ouyang; Dan L Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

5.  CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.

Authors:  Guifang Cai; Anukanth Anumanthan; Julia A Brown; Edward A Greenfield; Baogong Zhu; Gordon J Freeman
Journal:  Nat Immunol       Date:  2008-01-13       Impact factor: 25.606

6.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.

Authors:  John R Sedy; Maya Gavrieli; Karen G Potter; Michelle A Hurchla; R Coleman Lindsley; Kai Hildner; Stefanie Scheu; Klaus Pfeffer; Carl F Ware; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2004-11-28       Impact factor: 25.606

7.  Phenotypic analysis of antigen-specific T lymphocytes.

Authors:  J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

8.  An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection.

Authors:  Peggy Han; Olivia D Goularte; Kevin Rufner; Beverley Wilkinson; Jonathan Kaye
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

9.  Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells.

Authors:  C Kurts; H Kosaka; F R Carbone; J F Miller; W R Heath
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

10.  CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity.

Authors:  C Kurts; F R Carbone; M Barnden; E Blanas; J Allison; W R Heath; J F Miller
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

View more
  29 in total

Review 1.  The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.

Authors:  Marcos W Steinberg; Timothy C Cheung; Carl F Ware
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

2.  Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

Authors:  Eric F Tewalt; Jarish N Cohen; Sherin J Rouhani; Cynthia J Guidi; Hui Qiao; Shawn P Fahl; Mark R Conaway; Timothy P Bender; Kenneth S Tung; Anthony T Vella; Adam J Adler; Lieping Chen; Victor H Engelhard
Journal:  Blood       Date:  2012-09-19       Impact factor: 22.113

3.  Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity.

Authors:  Joseph Cantor; Marina Slepak; Nil Ege; John T Chang; Mark H Ginsberg
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

Review 4.  Breakdown in peripheral tolerance in type 1 diabetes in mice and humans.

Authors:  Lukas T Jeker; Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

5.  Dichotomous regulation of GVHD through bidirectional functions of the BTLA-HVEM pathway.

Authors:  Yukimi Sakoda; Jang-June Park; Yuming Zhao; Atsuo Kuramasu; Degui Geng; Yingjia Liu; Eduardo Davila; Koji Tamada
Journal:  Blood       Date:  2011-01-10       Impact factor: 22.113

Review 6.  Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling.

Authors:  Jr-Wen Shui; Marcos W Steinberg; Mitchell Kronenberg
Journal:  J Leukoc Biol       Date:  2010-11-24       Impact factor: 4.962

7.  Divide and conquer: Blocking graft versus host but not graft versus leukemia T cells with agonist BTLA co-inhibitory signals.

Authors:  Govindarajan Thangavelu; Colin C Anderson
Journal:  Chimerism       Date:  2011-01

8.  Putting the brakes on BTLA in T cell-mediated cancer immunotherapy.

Authors:  Chrystal M Paulos; Carl H June
Journal:  J Clin Invest       Date:  2009-12-28       Impact factor: 14.808

9.  BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.

Authors:  Laurent Derré; Jean-Paul Rivals; Camilla Jandus; Sonia Pastor; Donata Rimoldi; Pedro Romero; Olivier Michielin; Daniel Olive; Daniel E Speiser
Journal:  J Clin Invest       Date:  2009-12-28       Impact factor: 14.808

Review 10.  Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer.

Authors:  Pilar Martín; Rafael Blanco-Domínguez; Raquel Sánchez-Díaz
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.